The FEARS datasets include adverse drug events for mulitpe periods. The FDA released the datasets publicly. More information can be seen in the website of FDA:https://open.fda.gov/data/faers/
The purpose of this study is to evaluate the effectiveness, tolerability, and safety of oxymorphone immediate release (IR) oral liquid as an analgesic for acute postoperative pain in pediatric subje